Login / Signup

Broadly neutralizing monoclonal antibodies for HIV prevention.

Maurine D MinerLawrence CoreyDavid C Montefiori
Published in: Journal of the International AIDS Society (2021)
Iterative phase 1 trials are acquiring safety and pharmacokinetic data on dual and triple bnAbs and bi- and trispecific antibodies in preparation for future AMP studies that seek to translate findings from the VRC01 efficacy trials and achieve acceptable levels of overall prevention efficacy.
Keyphrases
  • current status
  • big data
  • computed tomography
  • image quality
  • molecularly imprinted
  • dual energy